Home › GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development
 

Keywords :   


GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development

2016-01-25 04:31:25| drugdiscoveryonline News Articles

GeneOne Life Science (KSE:011000) today announced the initiation of a collaborative research program with Inovio Pharmaceuticals (NASDAQ:INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.

Tags: life development science virus

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »